Literature DB >> 2425430

Isolation of a new human retrovirus from West African patients with AIDS.

F Clavel, D Guétard, F Brun-Vézinet, S Chamaret, M A Rey, M O Santos-Ferreira, A G Laurent, C Dauguet, C Katlama, C Rouzioux.   

Abstract

The etiological agent of AIDS, LAV/HTLV-III, is common in Central Africa but is not endemic in other areas of that continent. A novel human retrovirus, distinct from LAV/HTLV-III, has now been isolated from two AIDS patients from West Africa. Partial characterization of this virus revealed that it has biological and morphological properties very similar to LAV but that it differs in some of its antigenic components. Although the core antigens may share some common epitopes, the West African AIDS retrovirus and LAV differ substantially in their envelope glycoproteins. The envelope antigen of the West African virus can be recognized by serum from a macaque with simian AIDS infected by the simian retrovirus termed STLV-IIImac, suggesting that the West African AIDS virus may be more closely related to this simian virus than to LAV. Hybridization experiments with LAV subgenomic probes further established that this new retrovirus, here referred to as LAV-II, is distantly related to LAV and distinct from STLV-IIImac.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425430     DOI: 10.1126/science.2425430

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  253 in total

1.  JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.

Authors:  K Yoshimura; R Kato; K Yusa; M F Kavlick; V Maroun; A Nguyen; T Mimoto; T Ueno; M Shintani; J Falloon; H Masur; H Hayashi; J Erickson; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Multiplex detection of four pathogenic retroviruses using molecular beacons.

Authors:  J A Vet; A R Majithia; S A Marras; S Tyagi; S Dube; B J Poiesz; F R Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.

Authors:  R A Byrn; I Sekigawa; S M Chamow; J S Johnson; T J Gregory; D J Capon; J E Groopman
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  The monomeric and dimeric mannose-binding proteins from the Orchidaceae species Listera ovata and Epipactis helleborine: sequence homologies and differences in biological activities.

Authors:  E J Van Damme; J Balzarini; K Smeets; F Van Leuven; W J Peumans
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

5.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Authors:  A Karpas; G W Fleet; R A Dwek; S Petursson; S K Namgoong; N G Ramsden; G S Jacob; T W Rademacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.

Authors:  S Hayashi; S Phadtare; J Zemlicka; M Matsukura; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.

Authors:  N Manca; A Caruso; C Bonfanti; E Savoldi; R Li Vigni; F Pirali; P L Sapelli; A Turano
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

10.  Screening of African sera stored for more than 17 years for HIV antibodies by site-directed serology.

Authors:  F Chiodi; G Biberfeld; E Parks; E Norrby; M Mufson
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.